SCHEMBL20427134

SCHEMBL20427134

c1ccc(-c2ccc(-n3c4ccccc4c4ccc5c(ccn5-c5cc(-c6ccccc6)cc(-c6ccccc6)n5)c43)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ SCN9A Q15858 2/20 0.33
▸ CYP17A1 P05093 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ NR3C1 P04150 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20427157 0.97 L3MBTL1 (0.37) KDM4EL3MBTL1ATMSCN9ACYP17A1
SCHEMBL15802414 0.94 L3MBTL1 (0.37) KDM4EL3MBTL1ATMSCN9ACYP17A1
SCHEMBL20427132 0.93 CYP17A1 (0.31) SCN9ACYP17A1CYP19A1CYP11B1
SCHEMBL15801691 0.91 SCN9A (0.31) KDM4EL3MBTL1ATMSCN9ACYP17A1
SCHEMBL15857463 0.89 KDM4E (0.35) KDM4EL3MBTL1ATM
SCHEMBL15989439 0.88 KDM4E (0.34) KDM4EL3MBTL1ATMCYP17A1CYP19A1
SCHEMBL15857095 0.86 KDM4E (0.32) KDM4EL3MBTL1ATM
SCHEMBL15802235 0.86 KDM4E (0.34) KDM4EL3MBTL1ATMCYP17A1CYP19A1
SCHEMBL20427229 0.86 KMT2A (0.38) KDM4EL3MBTL1ATMCYP17A1CYP19A1
SCHEMBL15802276 0.85 KDM4E (0.31) KDM4EL3MBTL1ATMCYP17A1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU KDM4E 1494/4885L3MBTL1 464/4885ATM 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback